BACKGROUND:Autoantibodies to ApolipoproteinA-1 (anti-ApoA-1 IgG) were shown to predict major adverse cardiovascular events and promote atherogenesis. However, their potential relationship with clinical disability and ischemic lesion volume after acute ischemic stroke (AIS) remains unexplored. MATERIALS AND METHODS: We included n=76 patients admitted for AIS and we investigated whether baseline serum anti-ApoA-1 IgG levels could predict i) AIS-induced clinical disability (assessed by the modified Rankin Scale [mRS]), and ii) AIS-related ischemic lesion volume (assessed by Computed Tomography [CT]). We also evaluated the possible pro-apoptotic and pro-necrotic effects of anti-ApoA-1 IgG on human astrocytoma cell line (U251) using flow cytomet...
Background: As critical mediators of local and systemic inflammatory responses, cytokines are produc...
Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (ct...
Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (ct...
Autoantibodies against apolipoprotein A-I (anti-apoA-I IgGs) are prevalent in atherosclerosis-relate...
Autoantibodies against apolipoprotein A-I (anti-apoA-I IgGs) are prevalent in atherosclerosis-relate...
Objective: IgG antibodies against apolipoprotein A-I (ApoA-I) have been found to be elevated in subj...
OBJECTIVE: To determine whether anti-apolipoprotein A-1 (anti-Apo A-1) IgG are associated with major...
Autoantibodies against apolipoprotein A-I (anti-apoA-I IgGs) are prevalent in atherosclerosis-relate...
OBJECTIVE: To determine whether anti-apolipoprotein A-1 (anti-Apo A-1) IgG are associated with major...
AIMS: To assess the prognostic value of anti-apolipoprotein A-1 (anti-apoA-1) IgG after myocardial i...
We aimed at challenging the prognostic accuracies of myeloperoxidase (MPO) and antibodies anti-apoli...
We aimed at challenging the prognostic accuracies of myeloperoxidase (MPO) and antibodies anti-apoli...
ApoA-1 (apolipoprotein A-1) is the main component of HDL (high-density lipoprotein) and stabilizes P...
Immune-driven inflammation plays an important part in atherogenesis, and is therefore believed to be...
Background and Purpose—Immune responses to brain antigens occur after stroke, and experimental studi...
Background: As critical mediators of local and systemic inflammatory responses, cytokines are produc...
Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (ct...
Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (ct...
Autoantibodies against apolipoprotein A-I (anti-apoA-I IgGs) are prevalent in atherosclerosis-relate...
Autoantibodies against apolipoprotein A-I (anti-apoA-I IgGs) are prevalent in atherosclerosis-relate...
Objective: IgG antibodies against apolipoprotein A-I (ApoA-I) have been found to be elevated in subj...
OBJECTIVE: To determine whether anti-apolipoprotein A-1 (anti-Apo A-1) IgG are associated with major...
Autoantibodies against apolipoprotein A-I (anti-apoA-I IgGs) are prevalent in atherosclerosis-relate...
OBJECTIVE: To determine whether anti-apolipoprotein A-1 (anti-Apo A-1) IgG are associated with major...
AIMS: To assess the prognostic value of anti-apolipoprotein A-1 (anti-apoA-1) IgG after myocardial i...
We aimed at challenging the prognostic accuracies of myeloperoxidase (MPO) and antibodies anti-apoli...
We aimed at challenging the prognostic accuracies of myeloperoxidase (MPO) and antibodies anti-apoli...
ApoA-1 (apolipoprotein A-1) is the main component of HDL (high-density lipoprotein) and stabilizes P...
Immune-driven inflammation plays an important part in atherogenesis, and is therefore believed to be...
Background and Purpose—Immune responses to brain antigens occur after stroke, and experimental studi...
Background: As critical mediators of local and systemic inflammatory responses, cytokines are produc...
Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (ct...
Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (ct...